drugset / Trial / NCT02975219
Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis
NaSingle-groupOpen-labelTreatment
Summary
Incomplete resection of endometriosis lesions often results in recurrence of symptoms and the need for repeated surgery, with considerable associated morbidity. The aim of this pilot project is to determine the feasibility of fluorescence imaging to improve the treatment of endometriosis in the future.
Timeline
- Start
- 2017-05-01
- Primary completion
- 2019-01
- Completion
- 2019-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab-800CW | Diagnostic / imaging agent | 4.5 mg | Intravenous |